ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VTGN Vistagen Therapeutics Inc

2.60
0.35 (15.56%)
After Hours
Last Updated: 05:00:08
Delayed by 15 minutes

Vistagen Therapeutics Financial Summary

The current VTGN market cap is 72.39M. The company's latest EPS is USD -1.0545 and P/E is -2.37.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 178k277k412k197k84k
Operating Income -7M-6.78M-7.88M-11.36M-12.13M
Net Income -6.9M-6.59M-6.35M-9.52M-10.73M
Year End 31 March 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 01.09M1.11M-227k1.06M
Operating Income -20.8M-17.93M-47.78M-59.27M-33.02M
Net Income -22.04M-42.32M-48.71M-59.25M-29.36M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 15.03M42.2M131.07M123.65M113.55M
Total Liabilities 8.18M6.55M7.78M9.37M8.75M
Total Equity 6.85M35.65M123.29M114.29M104.8M
Year End 31 March 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 5.77M108.28M74.64M21.09M123.65M
Total Liabilities 11.5M16.3M9.93M9.01M9.37M
Total Equity -5.73M91.98M64.72M12.08M114.29M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -7.89M-14.08M-18.62M-25.81M-10.87M
Investing N/A N/A -32k-61k-5.47M
Financing 875k35.05M128.57M128.4M88k
Year End 31 March 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -15.76M-12.07M-45.26M-49.72M-25.81M
Investing N/A -275k-200k-740k-61k
Financing 4.01M114.1M10.48M-1.04M128.4M
Market Cap 72.39M
Price to Earnings Ratio -2.37
Price to Sales Ratio 65.45
Price to Cash Ratio 0.58
Price to Book Ratio 0.61
Dividend Yield -

Share Statistics

Shares Outstanding 27.84M
Average Volume (1 week) 308.07k
Average Volume (1 Month) 234.98k
52 Week Change -51.31%
52 Week High 5.86
52 Week Low 2.22
Spread (Intraday) 0.97 (32.33%)

Company Info

Company Name Vistagen Therapeutics Inc
Address 701 s carson st
carson city, nevada 89701
Website https://www.vistagen.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock